HH Biotechnology Holdings Co. Stock Analysis HHBT
HH Biotechnology Holdings Co. through its various subsidiaries, is engaged in the commercial and residential real estate leasing, management, consulting, investment, development and sales in the city of Shenyang, Liaoning Province, in the People' Republic of China. The company is headquartered in Shenyang, Liaoning. The company went IPO on 2012-07-23. The firm operates through two segments. The Property for Sale segment is primarily engaged in real estate sales. The Rental Income and Income of Management Fee of Commercial Buildings segment is primarily engaged in rental income and management fee income of commercial buildings. The firm conducts all operations through its direct and indirect subsidiaries, which include Shenyang Maryland International Industry Company Limited and Silverstrand International Holdings Company Limited. The firm is focused primarily on real estate leasing, management and consulting activities in the city of Shenyang.
Read More HH Biotechnology Holdings Co (HHBT) Chart
Key Statistics of HH Biotechnology Holdings Co (HHBT)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
7589.00P/E Ratio (TTM)
0.0052 Week Range
Market Cap
1406.00Avg. Volume
8355.00Dividend Yield
-Financial Metrics & Statements of HH Biotechnology Holdings Co (HHBT)
Super Investors Invested in HH Biotechnology Holdings Co (HHBT)
FAQ's for HH Biotechnology Holdings Co (HHBT)
- As of July 2026, HH Biotechnology Holdings Co HHBT is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes HH Biotechnology Holdings Co using these criteria to determine its compliance status.
- Muslim investors may consider investing in HH Biotechnology Holdings Co if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of HH Biotechnology Holdings Co by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of HH Biotechnology Holdings Co may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of HH Biotechnology Holdings Co on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
